Tumor-derived extracellular vesicles: A potential novel liquid biomarker for pancreatic ductal adenocarcinoma.
Roman O. Kowalchuk(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), E K Bauer(Mayo Clinic in Arizona), William S. Harmsen(Mayo Clinic), Rondell P. Graham(Mayo Clinic in Arizona), Cornelius A. Thiels(Mayo Clinic in Arizona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Cameron M. Callaghan(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Krishan R. Jethwa(Mayo Clinic), Fabrice Lucien(Université de Sherbrooke), Jonathan B. Ashman(Mayo Clinic in Arizona), Yohan Kim(Mayo Clinic in Arizona), Mark J. Truty(Mayo Clinic in Arizona), Aadel A. Chaudhuri(Mayo Clinic in Arizona), Terence T. Sio(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265